A Prospective Study of Cyclosporine A 0.1% Combined with Loteprednol 0.2% vs Cyclosporine A 0.05% Alone in the Treatment of Dry Eye

PURPOSE: To examine the efficacy and tolerability of a combination of cyclosporine 0.1% and loteprednol 0.2% (CsA–LE; Klarity CL) in comparison to commercially available cyclosporine 0.05% (CsA; Restasis) in improving signs and symptoms of dry eye. METHODS: This multicenter, prospective, randomized,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hovanesian, John, Chester, Thomas, Sorenson, Robert C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404532/
https://www.ncbi.nlm.nih.gov/pubmed/37554931
http://dx.doi.org/10.2147/OPTH.S419600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404532/
https://www.ncbi.nlm.nih.gov/pubmed/37554931
http://dx.doi.org/10.2147/OPTH.S419600

Ejemplares similares